Jerome Wong - 09 Dec 2025 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role: Chief Financial Officer
Signature: /s/ Jerome Wong
Issuer symbol: EKSO
Transactions as of: 09 Dec 2025
Net transactions value: -$5,819
Form type: 4
Filing time: 10 Dec 2025, 16:05:22 UTC
Previous filing: 12 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Wong Jerome	Chief Financial Officer	101 GLACIER POINT, SUITE A, SAN RAFAEL	/s/ Jerome Wong	10 Dec 2025	0001932326

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EKSO	Common Stock	Sale	$5,819	-1,238	-4.8%	$4.70	24,771	09 Dec 2025	Direct	F1, F2, F3
holding	EKSO	Common Stock						2,876	09 Dec 2025	By 401(k)	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares sold by the Reporting Person on December 9, 2025 to cover tax withholding obligations incurred upon the vesting and settlement of restricted stock awards originally reported by the Reporting Person in Form 4 filed with the Commission on June 15, 2023.
F2	These shares were sold in a single transaction at a price of $4.7048 per share.
F3	On June 2, 2025, the Issuer effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.